BB Biotech AG operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BB Biotech AG with three other
miscellaneous service companies in Europe:
sales of 9.75 million Euro [US$11.47 million]
of which 63%
of the United Kingdom
(£9.13 million [US$12.25 million]
of which 100%
was Medical Service), and
Avantium Holding BV
based in the Netherlands
(10.49 million Euro [US$12.34 million]
of which 98%
Sales fell dramatically in 2016:
BB Biotech AG reported sales of 12.16 million Swiss Francs (US$12.26 million)
December of 2016.
decrease of 95.8%
versus 2015, when the company's sales were 292.00 million Swiss Francs.